ICP Monitoring 3: Brain Tissue Oxygen Monitoring
Brain Tissue Oxygen (Pbt02) is a vital parameter measured to assess the outcome of the traumatic brain injury patient. This module defines and describes the role of brain tissue oxygen monitoring in TBI care.
Some of the topics covered include:
Presenter, Dr. Sylvain Palmer, MD, FACS, is a neurosurgeon at Mission Hospital and Regional Medical Center in Mission Viejo, CA. He also practices at Saddleback Memorial Hospital and Irvine Medical Center. He received his MD from Johns Hopkins University and completed his surgical internship and neurosurgical residency there as well. He specializes in minimally invasive spine surgery and uses the latest innovative techniques to perform out-patient surgery, minimizing postoperative discomfort and disability. Dr. Palmer has been instrumental in the development of many of these techniques and regularly teaches advanced spine techniques to other spine professionals throughout the world. He has presented and published his experience in minimally invasive decompressive spine procedures, minimally invasive fusions, and minimally invasive instrumentation at various professional meetings and journals. He is a member of a number of professional organizations including AANS-CNS Section on Disorders of the Spine, American Association of Neurological Surgeons, Congress of Neurological Surgeons, and North American Spine Society.
Presenter, Mary Kay Bader, MSN, RN, CS, CCRN, CNRN, is a Neuroscience Clinical Nurse Specialist at Mission Hospital and Regional Medical Center in Mission Viejo, CA. Ms. Bader also serves on the Brain Trauma Foundation's Medical Advisory Board. She is an expert in the critical care field, with nursing expertise in traumatic brain injury. She has authored a number of articles on the use of new technology to change nursing practice for patients with traumatic brain injury. Her research has appeared in a number of peer-reviewed publications, including the Journal of Neuroscience Nursing, Critical Care Nurse, Neurocritical Care, and AACN Clinical Issues.
In accordance with ACCME standards for commercial support of continuing medical education, faculty members have been asked to disclose any relationship they may have with commercial supporters of this CE activity or with companies providing drugs, medical equipment, etc that may have relevance to the content of the presentation. Such disclosure is intended to provide participants with sufficient information to evaluate whether any given presentation has been influenced by the faculty's relationship(s) or financial interests with said companies.
The following faculty reported having no financial interest or affiliation from a commercial supporter(s) or from a corporate organization that: (a) has a direct interest in the subject matter of the presentation or (b) has provided financial support to underwrite this activity: Sylvain Palmer, MD, and Mary Kay Bader, RN.